Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptor superfamily ligand-activated transcription factors that include the following three subtypes: PPAR, PPAR, and PPAR/. Higher organisms' cellular differentiation, development, metabolism (carbohydrate, lipid, and protein), as well as tumorigenesis, are all crucially regulated by PPARs. All PPARs bind to particular regions of the target genes' DNA through heterodimerization with the retinoid X receptor (RXR). Triglyceride levels are reduced and energy homeostasis is regulated when PPAR- is activated. PPAR- activation improves the metabolism of glucose, whereas PPAR-/ activation improves the metabolism of fatty acids.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
V52152 | DSO-5a | 2195411-63-1 | DSO-5a is a specific, orally bioactive BB3 agonist. | |
V3186 | Elafibranor | 923978-27-2 | Elafibranor (formerly GFT505) is a dual agonist of the PPARα/δ (peroxisome proliferator-activated receptor-α and -δ) with EC50 values of 45 and 175 nM, respectively. | |
V51333 | Fenofibric acid-d6 | 1092484-69-9 | Fenofibric acid-d6 (FNF acid-d6), deuterium labeled Fenofibric acid. | |
V55720 | Foenumoside B | 877661-00-2 | Foenumoside B is a triterpene saponin extracted from Lysimachia foenum-graecum. | |
V54438 | FTX-6746 | 2829349-96-2 | FTX-6746 is an orally bioactive PPARG inhibitor. | |
V67761 | FX-909 | 2924573-90-8 | FX-909 is a covalent peroxisome proliferator-activated receptor gamma (PPARG) inverse agonist. | |
V51061 | FX-909 | FX-909 is an inverse agonist of the covalent peroxisome proliferator-activated receptor gamma (PPARG). | ||
V54439 | Gancaonin L | 129145-50-2 | Gancaonin L is an isoflavone extracted from Glycyrrhiza glabra. | |
V52622 | Gemfibrozil-d6 (CI-719-d6) | 1184986-45-5 | Gemfibrozil-d6 is the deuterium labelled form of Gemfibrozil. | |
V3035 | GSK0660 | 1014691-61-2 | GSK0660 is a potent and selective antagonist of PPARβ and PPARδ with IC50values of both 155 nM, it has little or no activity on PPARα and PPARγ with IC50values of >10 μM. | |
V3544 | GW 501516 | 317318-70-0 | GW 501516 (also known as endurobol; GW-501516; GSK-516) is a novel and potent PPARδ agonist with an EC50 of 1.1 nM. | |
V60007 | GW-590735 | 343321-96-0 | GW 590735 is a potent and specific PPARα agonist. | |
V4928 | GW-7647 | 265129-71-3 | GW7647 (GW-7647) is a novel, selective and potent agonist of human and murine PPARα4 with EC50s of 6 nM, 1.1 μM, and 6.2 μM for human PPARα, PPARγ and PPARδ, respectively. | |
V4936 | GW1929 | 196808-24-9 | GW1929 is a novel, potent and selective PPAR-γ agonist with a pKi of 8.84 for human PPAR-γ, and pEC50s of 8.56 and 8.27 for human PPAR-γ and murine PPAR-γ, respectively. | |
V51335 | GW9662-d5 | 2117730-84-2 | GW9662-d5, deuterium labeled GW9662. GW9662 is a novel antagonist of PPARγ that exhibits selectivity over PPARα and PPARδ of 10 and 1000 times, respectively, at an IC50 of 3.3 nM. | |
V5144 | Indeglitazar (PPM 204 and PLX 204) | 835619-41-5 | Indeglitazar (formerly PPM-204 and PLX-204) is a novel, potent and orally bioavailable peroxisome proliferator-activated receptor (PPAR) pan-agonist for all three PPAR subtypes alpha (α), delta (δ) and gamma (γ). | |
V67759 | KD-3010 | 934760-92-6 | KD-3010 is an orally bioactive, potent and specific PPARδ agonist. | |
V3029 | Lanifibranor | 927961-18-0 | Lanifibranor (formerly named as IVA-337) is a novel, potent and well balanced agonist of the pan-peroxisome proliferator-activated receptors (PPAR) with excellent safetyprofiles and with EC50s of 1.5, 0.87 and 0.21 μM for human PPARα, PPARσ and PPARγ, respectively. | |
V31420 | LJ570 | 2252488-69-8 | LJ570 is a dual PPARα/PPARγ agonist with EC50 of 1.05 and 0.12 μM. | |
V24880 | MA-0204 | 2095128-17-7 | MA-0204 is a highly potent and selective PPARd modulator (PPARδ EC50 = 0.4 nM; PPARalpha, EC50 == 6,660 nM) that upregulates the expression of FAO genes in human renal proximal tubule cells, resulting in increased mitochondrial fatty acid oxidation. |